by winston | Sep 16, 2019 | 2019, News, Uncategorized
SWK Holdings to Present at the Fall Investor Summit Presentation Scheduled for Today, September 16, 2019, at 4:30 p.m., ET Dallas, TX, September 16, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company,...
by winston | Sep 6, 2019 | 2019, News, Uncategorized
Dallas, TX, September 6, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $2.1 million of...
by winston | Sep 3, 2019 | 2019, News
SWK Expands Board of Directors to Meet NASDAQ Listing RequirementsDallas, TX – September 3, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today that the Company has submitted its formal...
by winston | Aug 27, 2019 | 2019, News
SWK Holdings Corporation acquires 100% of Enteris’ equityEnteris to operate as an independent, wholly-owned subsidiary of SWK, targeting opportunities to develop and advance orally delivered peptide and small molecule therapeuticsNatural extension of SWK’s life...
by winston | Aug 12, 2019 | 2019, News
Total revenues of $5.7 million for the second quarter 2019 compared to $6.8 million for the second quarter 2018.Consolidated net income of $4.3 million, or $0.34 per share, and non-GAAP adjusted consolidated net income of $4.3 million, or $0.33 per share for the...
by admin | May 15, 2019 | 2019, News
Total revenues of approximately $9.4 million for the first quarter of 2019 compared to $6.8 million for the first quarter of 2018.Net income of $6.6 million, or $0.51 per share, and non-GAAP Adjusted net income of $7.4 million, or $0.57 per share for the first quarter...
